Stockscreener 앱 받기
0.3221
6.44%
0.0195
Biomerica Inc 주식(BMRA)의 최신 뉴스
Biomerica secures patents for GI treatments in Europe By Investing.com - Investing.com South Africa
Biomerica secures patents for GI treatments in Europe - Investing.com India
Biomerica Secures Three Key International Patents for inFoods® Technology to Address GERD, Crohn's Disease, and Ulcerative Colitis - The Manila Times
Biomerica Secures Major European Patents for $8B+ Disease Treatment Technology | BMRA Stock News - StockTitan
Granahan Investment Management Reduces Stake in Biomerica Inc - GuruFocus.com
Biomerica granted Nasdaq compliance extension By Investing.com - Investing.com South Africa
Biomerica granted Nasdaq compliance extension - Investing.com India
Nasdaq grants Biomerica an additional 180 days to meet listing compliance requirements - The Manila Times
Biomerica granted extension to regain Nasdaq compliance - Investing.com India
Biomerica granted extension to regain Nasdaq compliance By Investing.com - Investing.com Canada
Biomerica Gains on IBS Announcement - Baystreet.ca
Biomerica Announces Direct-to-Consumer Availability of inFoods® IBS Test, Targeting Relief for Bloating and Gastrointestinal Pain - The Manila Times
Biomerica Reports First Quarter Fiscal 2025 Financial Results - The Manila Times
Japan Point of Care Test Market By Application - Third Eye News
Labcorp Expands Sexually Transmitted Infection (STI) Test Offerings with Rapid Syphilis Test - Quantisnow
Blood Testing Market Size, Growth, Opportunities 2024-2032 | - openPR
Blood Testing Instrument Market 2031 Research Report, Growth Trends And Competition | Genteel, Baxter, Danaher, Hologic, Biomerica, Meridian Bioscience, Abbott – Times-BD24 - Times-BD24
Blood Testing Market Reaches USD 169.15 Billion by 2032 Due - GlobeNewswire
Artificial intelligence: who are the leaders in personalized food recommendation for the consumer industry? - just-food.com
Short Interest in Biomerica, Inc. (NASDAQ:BMRA) Increases By 582.1% - Defense World
Industrial Microbiology Market Share and Size 2024 In The Latest Report - WhaTech
Short Interest in Biomea Fusion, Inc. (NASDAQ:BMEA) Expands By 7.8% - Defense World
Ra capital executives buy Bicara Therapeutics shares for $32.99m - Investing.com India
Bokf Na Acquires Shares of 375 BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) - Defense World
BioMarin Pharmaceutical (NASDAQ:BMRN) Price Target Cut to $115.00 by Analysts at Bank of America - Defense World
BioMarin price target lowered to $115 from $130 at BofA - TipRanks
BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Shares Purchased by Acadian Asset Management LLC - Defense World
BioE3 Policy implementation and potential in Futuristic growth of J&K - Daily Excelsior
Nasdaq Gains 100 Points; Biomerica Shares Spike Higher - MSN
The United States Blood Testing Market Size & Outlook, 2030 - Grand View Research
Views of Wall Street’s Leading Experts on Biomerica Inc. - SETE News
Biomerica Inc. [BMRA] Stock trading around $0.38 per share: What’s Next? - The DBT News
BMRA’s 2023 Market Dance: Down -70.48% – Time to Invest? - The InvestChronicle
Saudi Arabia approves Biomerica's prostate cancer test - Investing.com
The Saudi Food and Drug Authority (SFDA) Approves Biomerica’s At Home PSA Screening Test to Detect Early Signs of Prostate Cancer - ForexTV.com
The Saudi Food and Drug Authority (SFDA) Approves Biomerica's At Home PSA Screening Test to Detect Early Signs of Prostate Cancer - StockTitan
Financial Metrics Exploration: Understanding Biomerica Inc. (BMRA) Through Ratios - The Dwinnex
Biomerica Full Year 2024 Earnings: US$0.35 loss per share (vs US$0.50 loss in FY 2023) - Yahoo Finance
Biomerica Reports Fiscal 2024 Year End Results - ForexTV.com
Biomerica (NASDAQ:BMRA) Stock Crosses Below 200-Day Moving Average of $0.66 - Defense World
Biomerica stock plunges to 52-week low of $0.28 - Investing.com India
Biomerica (NASDAQ:BMRA) Share Price Crosses Below 200 Day Moving Average of $0.76 - Defense World
Salmonella Testing Market Anticipated To Reach A CAGR Of 7.8% By 2031, Share, Size, Growth, Demand, And Seg... - WhaTech
Biomerica, Inc. (NASDAQ:BMRA) Short Interest Down 54.4% in June - Defense World
BMRABiomerica, Inc. Latest Stock News & Market Updates - StockTitan
Biomerica (NASDAQ:BMRA) Stock Passes Below 200-Day Moving Average of $0.83 - Defense World
Is Biomerica Inc. (BMRA) a good investment opportunity? – US Post News - US Post News
Financial Analysis: Biomerica Inc. (BMRA)'s Ratios Unveil Key Insights – DWinneX - The Dwinnex
Biomerica Launches At-Home Sample Collection for inFoods® IBS, Significantly Expanding Access for Millions of IBS Sufferers - StockTitan
Biomerica Launches At-Home Sample Collection for inFoods® IBS, Significantly Expanding Access for Millions of IBS ... - Afternoon Headlines
Biomerica (NASDAQ:BMRA) Stock Crosses Below Two Hundred Day Moving Average of $0.86 - Defense World
Biomerica Chairman Jack Kenny steps down By Investing.com - Investing.com Australia
Biomerica Chairman Jack Kenny Resigns Suddenly - TipRanks
Biomerica Chairman Jack Kenny steps down - Investing.com
Helicobacter Pylori Diagnostics Market Gaining Momentum with Positive External Factors - Taiwan News
0.65%
자본화:
|
볼륨(24시간):